Literature DB >> 2155997

Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant.

M E Boursnell1, P F Green, J I Campbell, A Deuter, R W Peters, F M Tomley, A C Samson, P Chambers, P T Emmerson, M M Binns.   

Abstract

In this paper we report on the identification of non-essential genes in the terminal repeats of the avipox-virus fowlpox virus and the use of these as insertion sites in a vector system. Foreign genes inserted into these sites are shown to be present in two copies in the resultant recombinant virus. To test the potential use of this vector as a live vaccine the fusion gene of Newcastle disease virus has been inserted into a vaccine strain of fowlpox virus and inoculated into chickens. The experiments demonstrate the ability of the recombinant to protect chickens against challenge by a virulent strain of Newcastle disease virus and to elicit the formation of an anti-fusion protein antibody.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155997     DOI: 10.1099/0022-1317-71-3-621

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.

Authors:  C Letellier; A Burny; G Meulemans
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 2.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages.

Authors:  R Zawatzky; H Wurmbaeck; W Falk; A Homfeld
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Potential use of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed in Rachiplusia nu larvae as an immunogen for chickens.

Authors:  Silvina Chimeno Zoth; Evangelina Gómez; Juan Manuel Carballeda; Oscar Taboga; Elisa Carrillo; Analía Berinstein
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

5.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus.

Authors:  C D Bayliss; R W Peters; J K Cook; R L Reece; K Howes; M M Binns; M E Boursnell
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens.

Authors:  J G Calvert; K Nazerian; R L Witter; N Yanagida
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10.

Authors:  Yan Zhao; Zongxi Han; Xiaocai Zhang; Xuemei Zhang; Junfeng Sun; Deying Ma; Shengwang Liu
Journal:  Virus Genes       Date:  2020-10-03       Impact factor: 2.332

9.  Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter.

Authors:  E Nagy; P J Krell; R A Heckert; J B Derbyshire
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

10.  Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins.

Authors:  Youn-Jeong Lee; Haan-Woo Sung; Jun-Gu Choi; Eun-Kyoung Lee; Hachung Yoon; Jae-Hong Kim; Chang-Seon Song
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.